entertainment -WSS

entertainment

author：leisure time 2025-10-01 01:50:03 - browse：8

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： FDA approves Sage Therapeutics’ rapid

WSS

FDA official pushes for dedicated emerging pathogens team

Court strikes down limits on filming of police in Arizona

How to ethically and practically extend health care to all

Study links childhood stress with decline in older age

A controversial new treatment promises to make little people taller

The cancer stories no one wants to hear

Wikipedia

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

Organ transplantation is at a crossroads. Major reform is needed

At least 13 dead in Texas as scorching temps continue

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

23andMe had bad news about my health. I wish a person had delivered it

Pharma showers House GOP doctor with campaign cash

Jerome Adams on the need for new antivirals for Covid

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Moonlake's readout produced a cash windfall. Risks remain

CDC backtracks, saying fully vaccinated people can go maskless indoors

explore

A double vaccine crisis is endangering millions of children

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Caitlin Bernard's story shows physicians can't shy from advocacy

Organ transplantation is at a crossroads. Major reform is needed

Russian special forces kill a gunman who broke into a private house near Moscow

When waiting feels immoral: Empathy in the emergency department

leisure time

focus

explore

entertainment